Tevogen Bio Holdings Inc. Common Stock (TVGN)
Tevogen Bio Holdings Inc. (TVGN) is a biopharmaceutical company focused on developing innovative therapies, including vaccines and treatments for infectious diseases. The company aims to leverage scientific advancements to address unmet medical needs through its research and development efforts.
Company News
Tevogen Bio is developing an investigational precision T cell therapy (TVGN 489) for COVID-19 and Long COVID, with a favorable safety profile demonstrated in clinical trials and plans to collaborate with government and healthcare organizations.
The global AI in healthcare market is projected to reach nearly $700 billion by 2034, growing at 38.5% annually. Companies are developing advanced AI diagnostic technologies targeting areas like diabetic retinopathy, cardiac screening, and chronic disease management, with increasing FDA approvals and commercial potential.